Campaign for NHS availability of Evusheld continues, as private procurement provides crucial protection for immunocompromised individuals.
As many of you know, I have been involved for the past few months in a campaign to get Evusheld – a protective/prophylactic drug for immunocompromised people who do not respond well to Covid vaccines – available on the NHS in the UK. We have not succeeded on that front yet and I am not giving up. However, for my own protection, since AstraZeneca made the drug privately available last week, I have been able to procure it privately.
No takes yet. Share an insight, caveat, or question.
Martin Paul Eve (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: